Description

Tesamorelin is a lab-engineered analog of growth hormone–releasing hormone (GHRH), designed with a structural modification that improves peptide stability in research environments. Through selective interaction with GHRH receptors, it is utilized in experimental models to stimulate and evaluate growth hormone production and release.

In laboratory and preclinical research, Tesamorelin is commonly studied for its receptor engagement characteristics, peptide durability, and its effects on regulation of the somatotropic (GH/IGF-1) axis. Its molecular design makes it a useful tool for investigating endocrine signaling dynamics and metabolic regulatory pathways under controlled conditions.

This compound is intended strictly for research use only and is not approved for human consumption, therapeutic use, or diagnostic applications.

Representative research sources include:
Falutz J. et al., Annals of Internal Medicine (2010)
Gelato M.C. et al., Journal of Clinical Endocrinology & Metabolism (2005)
Stanley T.L. et al., Journal of Clinical Endocrinology & Metabolism (2014)